Arabic Arabic English English French French German German
dark

Zynex Announces 247% Order Growth and Increases Q2 Adjusted EBITDA Estimate

Zynex, Inc. today announced orders and an increased Adjusted EBITDA estimate for Q2 2021. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

NLS Pharmaceutics Announces FDA Acceptance of IND Application to Initiate Clinical Trials with Quilience(R) (mazindol ER) to Treat Narcolepsy

Next Post

MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology

Related Posts
Total
0
Share